HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
Diabetes & Endocrinology
Meta-analysis
GnRHa treatment for central precocious puberty is associated with 2.7 cm greater adult height gain
GnRHa treatment helps girls with early puberty gain height
This meta-analysis of 35 noncomparative and 21 comparative observational studies evaluates GnRHa treatment in children with Central Precocio…
Girls with central precocious puberty who receive GnRHa treatment may gain an average of 2.7 cm more in adult height compared to those witho…
Jul 16, 2026
Diabetes & Endocrinology
Sys. Review
GnRHa treatment in familial hCG syndrome associated with concurrent beta-hCG elevation in blood and CSF
When a Pregnancy Hormone Shows Up in a Child — and It Is Not Cancer
This case report describes an 8-year-old girl with central precocious puberty treated with a gonadotropin-releasing hormone agonist (GnRHa).
An inherited condition can mimic a brain tumor in children by raising pregnancy hormones, leading to unnecessary surgery and chemotherapy be…
Frontiers
Apr 14, 2026